In a report released yesterday, Mark Massaro from Canaccord Genuity reiterated a Buy rating on Idexx Laboratories (IDXX), with a price target of $245. The company’s shares closed on Friday at $205.38.
According to TipRanks.com, Massaro is a 5-star analyst with an average return of 14.9% and a 56.2% success rate. Massaro covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, Meridian Bioscience Inc, and Quanterix Corporation.
Idexx Laboratories has an analyst consensus of Hold.
See today’s analyst top recommended stocks >>
Idexx Laboratories’ market cap is currently $17.81B and has a P/E ratio of 55.21. The company has a Price to Book ratio of -11101.62.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.
